Lifecore Biomedical Inc. (LFCR : NASDAQ)
Common Stock
$6.52
USD
+2.32 (55.24%)
Last updated: 2026-09-28
Follow LFCR
LFCR
Lifecore Biomedical Inc.
WealthAwesomePerformance
1 Day
+55.24%
1 Week
+45.54%
1 Month
+43.61%
YTD
+18.12%
Key Statistics
Market Cap
$246.80M
52W High
$8.98
52W Low
$3.63
P/E Ratio
-
50 Day MA
$4.47
200 Day MA
$5.70
Beta
1.08
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/28/2026 | $6.52 | $6.65 | $6.40 | $6.52 | $6.52 | 4,002,290 |
| 9/25/2026 | $4.27 | $4.39 | $4.12 | $4.20 | $4.20 | 70,500 |
| 9/24/2026 | $4.41 | $4.41 | $4.21 | $4.29 | $4.29 | 97,096 |
| 9/23/2026 | $4.45 | $4.49 | $4.39 | $4.40 | $4.40 | 205,201 |
| 9/22/2026 | $4.52 | $4.52 | $4.37 | $4.50 | $4.50 | 90,345 |
| 9/21/2026 | $4.48 | $4.51 | $4.21 | $4.48 | $4.48 | 170,703 |
| 9/18/2026 | $4.44 | $4.55 | $4.33 | $4.46 | $4.46 | 280,800 |
| 9/17/2026 | $4.22 | $4.48 | $4.16 | $4.46 | $4.46 | 144,713 |
| 9/16/2026 | $4.11 | $4.33 | $4.10 | $4.16 | $4.16 | 94,900 |
| 9/15/2026 | $4.21 | $4.23 | $4.13 | $4.14 | $4.14 | 76,100 |
Analyst Price Targets
Based on 3 analysts covering LFCR · as of Sep 17, 2026
Wall Street analysts forecast LFCR stock price to rise 3.5% over the next 12 months.
Consensus
Buy4.33 / 5.00
Avg. Target
US$6.75
+3.5% Upside
Current Price
US$6.52
Last close
Analyst Breakdown (3 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LFCR's historical volatility
30-Day Vol
138.1%
Annualized
90-Day Vol
99.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$7.79
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$6.92 | US$4.30 – US$11.14 |
| 60 trading days | US$7.34 | US$3.74 – US$14.41 |
| 90 trading days | US$7.79 | US$3.41 – US$17.79 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Lifecore Biomedical Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Financials
- Revenue (TTM)
- $129.46M
- EBITDA
- $8.24M
- Profit Margin
- -23.78%
- ROE (TTM)
- -76.41%
- EPS (Diluted)
- -1.27
- Book Value
- -0.90
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About LFCR.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DCX | Digital Currency X Technology Inc. | $6.17 | +12491.84% |
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.44 | +12100.00% |
| CTNT | Cheetah Net Supply Chain Service Inc. Class A Common Stock | $3.60 | +11150.00% |
| GMEX | GMEX ROBOTICS CORPORATION | $3.24 | +7880.30% |
| IFRX | InflaRx N.V. | $150.00 | +7836.51% |
| FBGL | FBS Global Limited Ordinary Shares | $4.30 | +1019.79% |
| KOD | Kodiak Sciences Inc | $89.92 | +177.96% |
| CLRO | ClearOne Inc | $5.10 | +47.83% |